The Polyclinic is a clinical research site located in Seattle, Washington, United States 98122.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
The Polyclinic has participated in 33 clinical trials.
Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Sponsors: National Cancer Institute (NCI), Celgene, SWOG Cancer Research Network.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Polyclinic has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Polyclinic has 33 clinical trials on record. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Yes — The Polyclinic holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.